Genia Long
Genia Long publishes mostly in Economics and Econometrics, Management of Technology and Innovation and Immunology, on topics such as Pharmaceutical Economics and Policy, Health Systems, Economic Evaluations, Quality of Life and Intellectual Property and Patents.
- World rank
- #1,058,296 of 7,710,434 ranked researchers
- Rank in United States
- #343,719 of 1,627,098
- Works
- 36
- Citations
- 672
- Citations per work
- 18.7
What does Genia Long research?
Genia Long's work is mostly in Economics, Econometrics and Finance (54%), Medicine (9%), Business, Management and Accounting (9%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Social Sciences2363.1%
- Everything else615.4%
- Health Sciences513.7%
- Medicine38.8%
- Health Professions24.9%
- Life Sciences37.8%
- 1Economics and Econometrics54% of their works
- 2Management of Technology and Innovation9% of their works
- 3Immunology8% of their works
- 4General Health Professions5% of their works
- 5Public Health, Environmental and Occupational Health5% of their works
- 6Cardiology and Cardiovascular Medicine4% of their works
Research topics
Which keywords describe Genia Long's research?
The keywords of their largest research topics: Drug Development Costs, Generic Drugs, Cost-effectiveness Analysis, Quality of Life, Innovation, Intellectual Property Rights, Patent Analysis and Biosimilars.
- Cost of Care
- Health Care Expenditure
- Ageing Population
- Global Collaboration
- Biosimilars
- Intellectual Property Rights
- Quality of Life
- Generic Drugs
- Drug Development Costs
- Cost-effectiveness Analysis
- Innovation
- Patent Analysis
- Immunogenicity
- Health Biotechnology
- Blood Pressure
- Hypertension
- Financial Toxicity
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 17 words, with their numbers
- Drug Development Costs261 topic
- Generic Drugs261 topic
- Cost-effectiveness Analysis231 topic
- Quality of Life231 topic
- Innovation142 topics
- Intellectual Property Rights91 topic
- Patent Analysis91 topic
- Biosimilars81 topic
- Immunogenicity81 topic
- Global Collaboration51 topic
- Health Biotechnology51 topic
- Ageing Population41 topic
- Blood Pressure41 topic
- Health Care Expenditure41 topic
- Hypertension41 topic
- Cost of Care31 topic
- Financial Toxicity31 topic
Where does Genia Long work?
Genia Long's main affiliation in the publication record is Analysis Group (United States), United States.
How many publications and citations does Genia Long have?
OpenAlex counts 36 works and 672 citations for Genia Long, an h-index of 11, ranking #1,058,296 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Genia Long. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.